Ferring International Center SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ferring International Center SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013475
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (follitropin delta), for controlled ovarian stimulation; Menopur (HP-hMG) for female and male infertility; Firmagon (degarelix) for prostate cancer; and Pentasa (mesalazine) for inflammatory bowel diseases. Its pipeline products encompass FE 999310 for infertility; FE 202767 for Lactation; Testavan for male hypogonadism; and Prefix for lumbar spine fusion, among others. Ferring conducts research and development on biotechnology derived medicines such as recombinant proteins and other biologics. It has production facilities in Argentina, Denmark, Germany, China, the Czech Republic, India, Scotland, Switzerland, Israel, Mexico, and a manufacturing site in the US. Ferring is headquartered at Saint-Prex, Switzerland.

Ferring International Center SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Ferring International Center SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Ferring International Center SA, Medical Devices Deals, 2011 to YTD 2017 10
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Ferring International Center SA, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 13
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women’s Health 15
Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 16
Ferring Pharma Acquires Assets from BioSurface Engineering 17
Ferring Pharma Acquires Ddavp from Sanofi 18
Ferring International To Acquire Assets Of Al-Kindi Pharma For US$6 Million 19
Partnerships 20
LIDDS Enters into Research Agreement with Ferring Pharma 20
Ferring International and Alrise Biosystems Enter into Co-Development Agreement 21
Ferring Pharma Enters into Agreement with CD Investments 22
Ferring Pharma Enters into Partnership with ICF 23
Ferring Pharma Enters into Agreement with Intralytix 24
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 25
Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 26
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 27
Ferring Pharma Enters into Co-Development Agreement with Roche 28
Ferring Pharma And Merck Enter Into Agreement With World Health Organization For Anti-Bleeding Drug 29
Ferring Pharma Enters Into Co-Promotion Agreement With Kyowa Hakko For Desmopressin Acetate 30
Licensing Agreements 31
Ferring International Enters into Licensing Agreement with Enteris BioPharma 31
Ferring International Enters into Licensing Agreement with IMAB 32
Ferring Pharma Enters into Licensing Agreement with Seikagaku 33
Ferring Pharma Enters into Licensing Agreement with Cosmo Pharma 34
Levo Therapeutics to Enter into Licensing Agreement with Ferring Pharma 35
TxCell Enters into Licensing Agreement with Ferring International for Ovasave 36
SciGen Expands Its Licensing Agreement With Ferring And Bio-Technology General 38
Acquisition 39
Ferring Pharma Acquires Cytokine PharmaSciences And Controlled Therapeutics 39
Ferring International Center SA – Key Competitors 40
Ferring International Center SA – Key Employees 41
Ferring International Center SA – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 47
Corporate Communications 47
Oct 02, 2017: Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer 47
May 23, 2017: Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth 48
Apr 03, 2017: Ferring appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer 49
Government and Public Interest 50
Jun 21, 2016: Ferring demonstrates commitment to R&D investment through expanded Innovation Grants Program 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Ferring International Center SA, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Ferring International Center SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Ferring International Center SA, Deals By Therapy Area, 2011 to YTD 2017 9
Ferring International Center SA, Medical Devices Deals, 2011 to YTD 2017 10
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 13
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women's Health 15
Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 16
Ferring Pharma Acquires Assets from BioSurface Engineering 17
Ferring Pharma Acquires Ddavp from Sanofi 18
Ferring International To Acquire Assets Of Al-Kindi Pharma For US$6 Million 19
LIDDS Enters into Research Agreement with Ferring Pharma 20
Ferring International and Alrise Biosystems Enter into Co-Development Agreement 21
Ferring Pharma Enters into Agreement with CD Investments 22
Ferring Pharma Enters into Partnership with ICF 23
Ferring Pharma Enters into Agreement with Intralytix 24
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 25
Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 26
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 27
Ferring Pharma Enters into Co-Development Agreement with Roche 28
Ferring Pharma And Merck Enter Into Agreement With World Health Organization For Anti-Bleeding Drug 29
Ferring Pharma Enters Into Co-Promotion Agreement With Kyowa Hakko For Desmopressin Acetate 30
Ferring International Enters into Licensing Agreement with Enteris BioPharma 31
Ferring International Enters into Licensing Agreement with IMAB 32
Ferring Pharma Enters into Licensing Agreement with Seikagaku 33
Ferring Pharma Enters into Licensing Agreement with Cosmo Pharma 34
Levo Therapeutics to Enter into Licensing Agreement with Ferring Pharma 35
TxCell Enters into Licensing Agreement with Ferring International for Ovasave 36
SciGen Expands Its Licensing Agreement With Ferring And Bio-Technology General 38
Ferring Pharma Acquires Cytokine PharmaSciences And Controlled Therapeutics 39
Ferring International Center SA, Key Competitors 40
Ferring International Center SA, Key Employees 41
Ferring International Center SA, Other Locations 43
Ferring International Center SA, Subsidiaries 43

★海外企業調査レポート[Ferring International Center SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aeon Co., Ltd.:企業の戦略・SWOT・財務分析
    Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • American Honda Motor Co Inc:企業の戦略的SWOT分析
    American Honda Motor Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Islet Sciences Inc (ISLT):企業の財務・戦略的SWOT分析
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • Quanta Services Inc (PWR):石油・ガス:M&Aディール及び事業提携情報
    Summary Quanta Services, Inc. (Quanta) is a specialized contracting services company that offers infrastructure solutions. It designs, installs, upgrades, repairs and maintains infrastructure of electric power transmission and distribution networks, substation facilities, renewable energy facilities …
  • Typhoon Exploration Inc (TYP):企業の財務・戦略的SWOT分析
    Summary Typhoon Exploration Inc (Typhoon Exploration) is a mineral exploration company. The company carries out acquisition, exploration and development of gold assets. It provides technology for exploration projects. Typhoon Exploration’s operational areas include Monexco, Fayolle, Faille 1, Destor …
  • Gujarat Industries Power Co Ltd (GIPCL):企業の財務・戦略的SWOT分析
    Gujarat Industries Power Co Ltd (GIPCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • China Southern Power Grid Co Ltd:電力:M&Aディール及び事業提携情報
    Summary China Southern Power Grid Co Ltd (CSG) is a power company that invests in construction, operations and management of the power grids. The company concentrates on developing regional power network, managing power dispatching and transaction center, administering regional power market, and dis …
  • Bakkavor Group Limited:企業の戦略・SWOT・財務情報
    Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cebu Air Inc:戦略・SWOT・企業財務分析
    Cebu Air Inc - Strategy, SWOT and Corporate Finance Report Summary Cebu Air Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Philippine Long Distance Telephone Co (TEL):企業の財務・戦略的SWOT分析
    Philippine Long Distance Telephone Co (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Marathon Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Marathon Pharmaceuticals LLC (Marathon Pharmaceuticals) focuses on the development, manufacturing and commercialization of treatments for rare neurological and movement disorders. It develops products in various therapeutic areas which include duchenne muscular dystrophy, pediatric juvenile …
  • The AES Corp (AES):企業の財務・戦略的SWOT分析
    The AES Corp (AES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Connected Energy:企業の戦略的SWOT分析
    Connected Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Mari Petroleum Co Ltd (MARI):企業の財務・戦略的SWOT分析
    Mari Petroleum Co Ltd (MARI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • University of Pennsylvania:医療機器:M&Aディール及び事業提携情報
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Genedrive Plc (GDR):企業の製品パイプライン分析
    Summary Genedrive Plc (Genedrive), formerly Epistem Holdings plc, develops and markets point of need molecular diagnostics platform for identifying infectious diseases and pathogens and providing other indications. The Genedrive HCVID test is the company’s CE-IVD certified molecular diagnostics plat …
  • PerkinElmer Inc (PKI)-医療機器分野:企業M&A・提携分析
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection, imaging, and informatics solutions and services to diagnostics, research, laboratory services, environmental, and industrial markets. The company’s product portfolio comprises lab products and services; imaging components; diagnostic …
  • Nitto Denko Corp (6988):製薬・医療:M&Aディール及び事業提携情報
    Summary Nitto Denko Corp (Nitto) is a manufacturer of diversified material, which produces electrical insulating material, electronics, industrial and functional products by harnessing its core technologies such as polymer synthesis, and adhesive and coating technologies. The company offers a broad …
  • NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Qlik Technologies Inc:企業のM&A・事業提携・投資動向
    Qlik Technologies Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Qlik Technologies Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆